&nbsp;

GOC-DocumentationTemplate-FR.pdf

Oct 2021

Document

GOC-DocumentationTemplate.pdf

Oct 2021

Regimen

MFOLFOX6+NIVL

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab - First-line Treatment of Advanced Gastric, Esophageal, and Esophagogastric Junction Adenocarcinoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2023

Drug

gemtuzumab ozogamicin

Other Name(s): Mylotarg®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Jun 2022

Regimen

GILT

Cancer Type:

Hematologic,

Leukemia - Acute Myeloid (AML)

Intent: Palliative

Funding:

Exceptional Access Program

gilteritinib - Relapsed or Refractory FLT3-mutated acute myeloid leukemia

Drugs Used:

gilteritinib

... Show more tags

Quick Link(s):

Regimen Monograph

Mar 2022

Measuring Ontario’s Small Area Inequalities in Cancer (MOSAIC) Study

Document

MOSAIC_Placemat.pdf

Jan 2022

Document

mosaicPlacemat.jpg

Feb 2022

Drug

gilteritinib

Other Name(s): Xospata®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Jul 2023

Regimen

GDCRBP+RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Curative

Funding:

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Aggressive Histology Lymphoma

ODB - General Benefit

dexamethasone

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Aggressive Histology Lymphoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Jan 2024

Regimen

MFOLFOX6+BEVA

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Funding:

New Drug Funding Program

Bevacizumab (Biosimilar) - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

MFOLFOX6

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Drugs Used: